Avsar.
TT

Diversified · Diversified

TTK Healthcare Ltd (TTKHLTCARE)

₹1,027.60

Mkt cap
₹1,484 Cr
P/E ratio
19.40
P/B
1.30
Div yield
0.95%
ROE
6.30%
ROCE
8.04%
EPS (TTM)
₹52.97
Book value
₹789
52W range
735–1,247
Sector
Diversified

Price history

Previous close

TTK Healthcare Ltd is a standalone TTK Group company in consumer /OTC brands, animal health, medical devices, condoms/sexual-wellness and ready-to-fry foods. Human Pharma was divested in May 2022; agreements to sell EVA and Good Home were signed in July 2026. [1] [2]

NSE TTKHLTCAREBSE 507747
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−17.59% from high
₹1,028
₹735+39.81% from low₹1,247
Current
₹1,027.60
Prev close
₹1,005.10
Day
+2.24%
Price performance
1D
+2.24%
1W
+1.38%
1M
−6.85%
3M
+10.36%
6M
+30.22%
1Y
−11.00%
YTD
−0.09%

Financials

Revenue, profit & margin
P/E ratio
19.4×
TTKHLTCARE is 45% above the sector median of 13.4×
TTKHLTCARE19.4×
Sector median13.4×
 Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Trend
Sales202186184181208198205190226204209218258
Expenses192176179169201190197178224198202207243
Operating Profit1010512788123571115
OPM %5.0%5%2.9%7%3.3%4.2%3.8%6%1.2%2.6%3.4%5%6%
Other Income15161616371818131819102117
Interest1101111111111
Depreciation3333222222222
Profit before tax21221824412323221821143029
Tax %24%26%27%25%23%26%26%26%26%4%25%26%26%
Net Profit16161318321717161320112221
EPS in Rs11.0911.339.1212.9322.3512.1711.8411.439.2014.437.4515.4015.06
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +4.61% · closed higher next day 1 of last 1
 Q1FY27
Broadcast6 Aug '26
Earnings day+4.61%
+1 day+3.72%
+5 days+8.91%
+15 days+3.28%
+30 days+0.39%
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Results analysis

Shareholding

as of Jun 2026
74.57%Promoter
Promoters74.57%
FIIs1.86%0.04
DIIs2.19%1.08
Public21.39%1.04
Ownership trend

Peers

7 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
3M India₹34,095.0087.1538,4250.47%233−0.42%1,423+19.00%50.01%
Godrej Industrie₹1,107.4031.0037,3030.00%523−18.57%5,448+22.16%8.17%
DCM Shriram₹995.0011.3315,5161.13%693+445.40%3,564+9.27%11.51%
Balmer Lawrie₹167.4110.262,8635.08%71+3.60%749+10.00%14.60%
TTK Healthcare₹1,050.0019.371,4840.95%21+63.69%258+13.75%8.04%
Empire Inds.₹1,057.1011.276342.36%14+47.30%184+10.07%17.95%
Maheshwari Logi.₹68.7013.362030.00%3−25.80%235−8.37%12.04%
Median: 7 Co.₹1,050.0013.362,8630.95%71+3.60%749+10.07%12.04%

Filings

Annual reports15
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016Annual Report 2015Annual Report 2014Annual Report 2013Annual Report 2012
Concall transcripts1
PPTSep 2016
Credit ratings6
Rating update 29 Sep 2025icraRating update 4 Sep 2023icraRating update 7 Jul 2022icraRating update 30 Mar 2022icraRating update 10 May 2021icraRating update 14 Apr 2020icra
Announcements5
Announcement Under Regulation 30 Of SEBI LODR Regulations. 4 Sep - TTK Healthcare received Rs.256 crore plus GST from Wipro; sale of EVA and Good Home brands closed.Appointment Of Tax Auditor Of The Company 2 Sep - TTK Healthcare appoints M/s. R V K & Co. as tax auditor for FY26-FY28.Intimation From M/S Aiyar & Co. Regarding Their Inability To Continue As Tax Auditors 27 Aug - Aiyar & Co. withdrew as tax auditor for FY 2025-26, effective August 26, 2026.Announcement under Regulation 30 (LODR)-Newspaper Publication 27 AugOutcome Of Board Meeting 6 Aug - TTK Healthcare reported Q1 FY27 results and disclosed Rs256 crore sale of EVA and Good Home brands.